Cytomegalovirus immunoglobulin (Cytotect CP Biotest)

Status:

Red

Decision Date:

March 2020

Comments

RED: Prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy.

 NHS England drug.  To be used in line with NHSE commissioning intentions.

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again